• Citer

Topoisomerase II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated with single-agent doxorubicin or single-agent docetaxel.

par Desmedt, Christine ;Durbecq, Virginie ;Paesmans, Marianne ;Sotiriou, Christos ;Leroy, Jean-Yves;Rouas, Ghizlane;Chan, S;Friedrichs, Kay;Pinter, Tamas;Van Belle, S.;Murray, Elizabeth;Perren, Thimothy J.;Olsen, S.;Di Leo, Angelo ;Cardoso, Fatima ;Piccart-Gebhart, Martine ;Larsimont, Denis
Référence AACR(95th: March 27-31, 2004: Orlando, FL, USA), Proceedings of the 95th Annual Meeting of the American Association for Cancer Research (abst.1150), Vol. 45, page (263)
Publication Publié, 2004-03

Abstract de conférence

• Détails

Titre:	Topoisomerase II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated with single-agent doxorubicin or single-agent docetaxel.
Auteur:	Desmedt, Christine; Durbecq, Virginie; Paesmans, Marianne; Sotiriou, Christos; Leroy, Jean-Yves; Rouas, Ghizlane; Chan, S; Friedrichs, Kay; Pinter, Tamas; Van Belle, S.; Murray, Elizabeth; Perren, Thimothy J.; Olsen, S.; Di Leo, Angelo; Cardoso, Fatima; Piccart-Gebhart, Martine; Larsimont, Denis
Informations sur la publication:	AACR(95th: March 27-31, 2004: Orlando, FL, USA), Proceedings of the 95th Annual Meeting of the American Association for Cancer Research (abst.1150), Vol. 45, page (263)
Statut de publication:	Publié, 2004-03
Sujet CREF:	Sciences bio-médicales et agricoles
	Médecine pathologie humaine
	Cancérologie
Langue:	Anglais